ANG Lifesciences India (BOM:540694) PE Ratio (TTM): At Loss (As of Aug. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540694 ANG Lifesciences India Ltd BOM:540694
60 GF Score
Price ₹34.30
GF Value ₹30.29
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is ANG Lifesciences India PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-05), ANG Lifesciences India's share price is ₹34.30. ANG Lifesciences India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-8.47. Therefore, ANG Lifesciences India's PE Ratio (TTM) for today is At Loss.


The historical rank and industry rank for ANG Lifesciences India's PE Ratio (TTM) or its related term are showing as below:

BOM:540694' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: 9.21   Max: 537.5
Current: At Loss


During the past 13 years, the highest PE Ratio (TTM) of ANG Lifesciences India was 537.50. The lowest was 0.00. And the median was 9.21.


BOM:540694's PE Ratio (TTM) is ranked worse than
100% of 639 companies
in the Drug Manufacturers industry
Industry Median: 21.03 vs BOM:540694: At Loss

ANG Lifesciences India's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was ₹-1.06. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-8.47.

As of today (2026-08-05), ANG Lifesciences India's share price is ₹34.30. ANG Lifesciences India's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-8.47. Therefore, ANG Lifesciences India's PE Ratio without NRI for today is At Loss.

During the past 13 years, ANG Lifesciences India's highest PE Ratio without NRI was 537.50. The lowest was 0.00. And the median was 9.03.

ANG Lifesciences India's EPS without NRI for the three months ended in Mar. 2026 was ₹-1.06. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-8.47.

During the past 3 years, the average EPS without NRI Growth Rate was -302.70% per year.

During the past 13 years, ANG Lifesciences India's highest 3-Year average EPS without NRI Growth Rate was 184.90% per year. The lowest was -302.70% per year. And the median was 58.90% per year.

ANG Lifesciences India's EPS (Basic) for the three months ended in Mar. 2026 was ₹-1.06. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-8.47.


ANG Lifesciences India  (BOM:540694) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


ANG Lifesciences India PE Ratio (TTM) Related Terms


ANG Lifesciences India PE Ratio (TTM) Historical Data

* Premium members only.

The historical data trend for ANG Lifesciences India's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ANG Lifesciences India PE Ratio (TTM) Chart

ANG Lifesciences India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.83 At Loss At Loss At Loss At Loss

ANG Lifesciences India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

BOM:540694 vs ZTS: PE Ratio (TTM) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANG Lifesciences India PE Ratio (TTM) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's PE Ratio (TTM) falls into.


BOM:540694
60GF Score
ANG Lifesciences India Ltd BOM:540694
PE Ratio (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ANG Lifesciences India PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

ANG Lifesciences India's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=34.30/-8.472
=At Loss

ANG Lifesciences India's Share Price of today is ₹34.30.
ANG Lifesciences India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-8.47.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Is ANG Lifesciences India (BOM:540694) Overvalued in 2026?

Based on GuruFocus' analysis, ANG Lifesciences India stock appears to be overvalued. The current stock price of ₹34.30 is trading 13.2% above its estimated GF Value™ of ₹30.29. GuruFocus considers ANG Lifesciences India to be Modestly Overvalued.

Key valuation signals for BOM:540694:

  • PE Ratio (TTM): At Loss
  • GF Value™: ₹30.29 vs. price of ₹34.30 (13.2% above fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the BOM:540694 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ANG Lifesciences India Business Description

Address Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is engaged in the business of manufacturing and sales of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, lotions, etc. Its product portfolio comprises various therapeutic categories such as antibiotics, antivirals, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, beta-lactamase inhibitor, etc. Through its subsidiary, it is also involved in the business of printing and packing solutions. The group's reportable segments are Pharmaceuticals, which derive maximum revenue, and Packaging and printing. Geographically, it derives maximum revenue from India.
60GF Score

Get the complete analysis for BOM:540694

PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹34.30
Price
₹30.29
GF Value